Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAB Foods Regulatory News (ABF)

Share Price Information for AB Foods (ABF)

Share Price is delayed by 15 minutes
Get Live Data
1,865.00    1.00 (0.05%)
Bid:
1,864.50
Ask:
1,865.00
Spread: 0.50 (0.027%)
Market Cap: £13.05b
ABF Live PriceLast checked at - London Stock Exchange

Intraday AB Foods Share Chart

Share repurchase programme

6 Nov 2024 07:00

RNS Number : 0713L
Associated British Foods PLC
06 November 2024
 

6 November 2024

 

Associated British Foods plc

 

Associated British Foods plc share repurchase programme

 

Further to its announcement on 5 November 2024, Associated British Foods plc (the "Company") announces that it is to commence the first tranche of its up to £500 million share buyback programme (the "Programme").

 

The first tranche will be in the sum of up to £250 million with trading to commence today and is anticipated to end on or before 15 April 2025 (the "Engagement Period").

 

To execute the first tranche of the Programme, the Company has entered into a non-discretionary arrangement with UBS AG London Branch ("UBS") to buy back up to £250 million of its ordinary shares (the "Engagement").

 

Under this arrangement, UBS will act as riskless principal and will make decisions independently from the Company under the Engagement. UBS will carry out the arrangement through the acquisition of ordinary shares in the Company for subsequent repurchase by the Company. Purchases may continue during any closed period to which the Company is subject during the Engagement Period.

 

The sole purpose of the share buyback is to reduce the capital of the Company. All ordinary shares repurchased as part of this arrangement will be cancelled.

 

Share purchases will take place in open market transactions and be carried out on the London Stock Exchange, BATS, Chi-X and Aquis exchanges and may be made from time to time depending on market conditions, share price, trading volume and other factors.

 

Any purchases of ordinary shares by the Company in relation to this announcement will be effected within certain pre-set parameters and in accordance with (and subject to the limits prescribed by) the Company's general authority to repurchase ordinary shares granted by its shareholders from time to time (at the Company's AGM on 8 December 2023, shareholders gave the Company authority to purchase a maximum of 76,519,596 ordinary shares of which 53,540,214 remains available), the Market Abuse Regulation 596/2014 (as it forms part of UK law pursuant to the European Union (Withdrawal) Act 2018) and Chapter 9.6 of the Financial Conduct Authority's UK Listing Rules.

 

The Company intends to enter into arrangements to commence a second tranche of the Programme in the sum of £250 million in due course.

 

Further enquiries:

Associated British Foods:

Tel: 020 7399 6545

Eoin Tonge, Finance DirectorChris Barrie, Corporate Affairs Director

 

Citigate Dewe Rogerson:

Tel: 020 7638 9571

Kevin Smith

Tel: 07710 815924

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBIBDBUBGDGSU
Date   Source Headline
5th Nov 20197:05 amRNSFinal dividend for year ended 14 September 2019
5th Nov 20197:00 amRNSAnnual Results
1st Oct 201910:38 amRNSDirector Declaration
11th Sep 20195:04 pmRNSDirector/PDMR Shareholding
9th Sep 20197:00 amRNSPre Close Period Trading Update
3rd Sep 20193:09 pmRNSDirector/PDMR Shareholding
2nd Aug 20193:51 pmRNSDirector/PDMR Shareholding
25th Jul 20195:47 pmRNSDirector Declaration
12th Jul 20199:06 amRNSDirector/PDMR Shareholding
12th Jul 20199:01 amRNSDirector/PDMR Shareholding
4th Jul 20197:00 amRNSTrading Update
24th Apr 20197:05 amRNSInterim dividend
24th Apr 20197:00 amRNS2019 Interim Results Announcement
3rd Apr 201910:44 amRNSDirector Declaration
1st Mar 20195:41 pmRNSDirector/PDMR Shareholding
25th Feb 20197:00 amRNSPre Close Period Trading Update
17th Jan 20197:00 amRNSTrading Update
16th Jan 20199:00 amRNSDirector/PDMR Shareholding
7th Dec 20183:07 pmRNSResult of AGM
7th Dec 20187:00 amRNSAGM Trading Statement
27th Nov 20183:52 pmRNSDirector/PDMR Shareholdings
21st Nov 20186:34 pmRNSDirector/PDMR Shareholding
8th Nov 201810:30 amRNSAnnual Report and Accounts 2018
6th Nov 20187:01 amRNSFinal dividend for the year
6th Nov 20187:00 amRNSAnnual Results
22nd Oct 201811:08 amRNSHoldings in Company
10th Sep 20187:00 amRNSPre Close Period Trading Update
5th Sep 20184:22 pmRNSDirectorate Change
23rd Jul 20183:59 pmRNSDirector / PDMR announcement for John Bason
6th Jul 20184:55 pmRNSDirector/PDMR Shareholding
5th Jul 20187:00 amRNSTrading Update
30th May 20189:39 amRNSDirector/PDMR Shareholding
18th Apr 20183:28 pmRNSDirector/PDMR Shareholding
17th Apr 20187:05 amRNSInterim Dividend
17th Apr 20187:00 amRNSInterim Results announcement
27th Feb 20184:22 pmRNSDirector/PDMR Shareholding
26th Feb 20187:00 amRNSTrading Statement
22nd Feb 201810:00 amRNSDirectorate Change
18th Jan 20187:00 amRNSTrading Update
15th Jan 20185:04 pmRNSDirector/PDMR Shareholding
3rd Jan 201810:57 amRNSDirector Declaration
8th Dec 20173:46 pmRNSResult of AGM
8th Dec 201711:03 amRNSChairman's Address to AGM
28th Nov 20172:34 pmRNSDirector/PDMR Shareholding
22nd Nov 20172:56 pmRNSDirector/PDMR Shareholding
9th Nov 20179:42 amRNSAnnual Report & Accounts 2017 & associated docs
7th Nov 20177:04 amRNSDividend Declaration
7th Nov 20177:00 amRNSResults For 52 Weeks Ended 16 September 2017
11th Sep 20177:00 amRNSPre Close Period Trading Update
7th Sep 20179:24 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.